´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÆ÷Áö¾ö : 2021-04-02±³À°ÀÏÀÚ : 2021-04-02
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À° (½Ç½Ã°£ È»ó °ÀÇ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021³â Ãá°è½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914
À̸ÞÀÏ :
kscp3@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø-10¸¸¿ø/ÁØȸ¿ø-8¸¸¿ø/ºñȸ¿ø-25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 09:00~09:30 (Workshop 4) ¼±ÃµÁúȯ Áø´Ü¿ë NGS Æгΰ˻çÀÇ ÇöȲ°ú ¿î¿ë °æÇè ¿À½Âȯ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 09:30~10:00 (Workshop 4) Ç÷¾×Á¾¾ç Áø´ÜÀ» À§ÇÑ NGS ÆгΠ°Ë»çÀÇ ÇöȲ°ú °æÇè Á¶¿µ¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 10:00~10:30 (Workshop 4) ±¹³» NGS ÆгΠ°Ë»çÀÇ ÀÓ»ó Àû¿ë °³¼± ¹æÇâ ÀÌ°æ¾Æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 10:40~11:40 (Plenary Session 2) Clinical applications of antibody tests for COVID-19 diagnosis Maurizio Sanguinetti(European Society of Clinical Microbiology and Infectious Diseases Italy)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 13:00~13:40 (Keynote Session 1) The global problem of antifungal resistance: prevalence, mechanisms, and management David S. Perlin(Center for Discovery and Innovation- Hackensack Meridian Health USA)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 13:50~14:20 (Symposium 8) ABO genotyping : Methods and Clinical applications ±èÅ¿(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 14:20~14:50 (Symposium 8) ABO ºÒÀÏÄ¡ Àå±âÀ̽Ľà ¼öÇ÷ °í´ëÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 14:50~15:20 (Symposium 8) ABO Ç÷¾×Çü°ú Äڷγª °¨¿° ±è°æÈñ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 13:50~14:20 (Symposium 9) ½ÉºÎÀü Áø´Ü ¸¶Ä¿µéÀÇ ¼Ò°³ Á¤Åµ¿(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 14:20~14:50 (Symposium 9) Æ®·ÎÆ÷´Ñ °Ë»çÀÇ ÃֽŠÁö°ß ¹× È°¿ëµµ Á¶ÁÖ¿µ(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 14:50~15:20 (Symposium 9) ½ÉÇ÷°üÁúȯ À§Çèµµ ¿¹Ãø º¸Á¶ ÁöÇ¥: Lipoprotein(a), hsCRP, Homocysteine ¹®¼ö¿µ(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 16:00~16:30 (Workshop 5) Äڷγª19 ¿¹¹æÀ» À§ÇÑ È¯°æ °ü¸®: ¼Òµ¶Á¦ ¹× ȯ°æ ¼Òµ¶ ±èÅüö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 16:30~17:00 (Workshop 5) Äڷγª19 ¿¹¹æÀ» À§ÇÑ °³ÀÎ ¹æ¿ª: ¸¶½ºÅ© ¹× ¼ÕÀ§»ý ±è¼º¶õ(°í´ë±¸·Îº´¿ø °¨¿°°ü¸®½Ç)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 17:00~17:30 (Workshop 5) Äڷγª19 °¨¿°°ü¸®¸¦ À§ÇÑ Áø´Ü°Ë»çÀÇÇаúÀÇ ¿ªÇÒ (ÀÇ·á±â°ü) È«±âÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 17:30~18:00 (Workshop 5) Äڷγª19 °¨¿°°ü¸®¸¦ À§ÇÑ Áø´Ü°Ë»çÀÇÇÐȸÀÇ ¿ªÇÒ (±¹°¡Á¤Ã¥) ±è°©Á¤(Áúº´°ü¸®Ã» °¨¿°º´Áø´Ü°ü¸®ÃÑ°ý°ú)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:00~16:15 (Workshop 6) ÀÚµ¿Ç÷±¸ºÐ¼®±â¸¦ ÀÌ¿ëÇÑ Ã¼¾×¼¼Æ÷ºÐ¼®ÀÇ ±¹³» ÇöȲ Á¶»ç ¹× °Ë»ç½Ç Àû¿ë, °ËÁõ/È®Àΰú Á¤µµ°ü¸®¸¦ À§ÇÑ Áöħ Á¦¾È Á¶¿µ¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:15~16:30 (Workshop 6) °£Á¢¸é¿ªÇü±¤¹ý ANCA °Ë»ç Æǵ¶ °¡À̵å Á¦¾È ½Å°æÈ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:30~16:45 (Workshop 6) ÁøÇ༺ ºñ¼Ò¼¼Æ÷¼º Æó¾Ï¿¡¼ EGFR µ¹¿¬º¯ÀÌ °ËÃâÀ» À§ÇÑ ¼¼°¡Áö Áø´Ü Àü·«ÀÇ ºñ¿ë È¿°ú ºÐ¼® ÀÌ°æ¾Æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:45~17:00 (Workshop 6) ±¹³»¿¡¼ »ç¿ëÇÏ´Â lectin½Ã¾àÀÇ ¹ÝÀÀµµ ºñ±³ Æò°¡ ÀÓÁöÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 02ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 17:00~17:30 (Workshop 6) °Ë»çÁ¤º¸½Ã½ºÅÛ(LIS)ÀÇ ±ÇÀå»çÇ× ÃÊ¾È ¼Ò°³ ±èÇö±â(¿ï»êÀÇ´ë)